Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 222,170 | 231,271 | 241,302 | 247,082 | 221,348 |
| Marketable Securities | N/A | 0 | 0 | N/A | 37,732 |
| Receivables | 886 | 1,785 | 1,029 | 1,117 | 449 |
| TOTAL | $225,274 | $235,896 | $243,570 | $249,229 | $260,992 |
| Non-Current Assets | |||||
| PPE Net | 4,169 | 4,335 | 3,985 | 3,565 | 3,187 |
| Intangibles | 5,000 | 16,200 | 16,650 | 0 | 0 |
| Other Non-Current Assets | 140 | 140 | 140 | 140 | 140 |
| TOTAL | $9,309 | $20,675 | $20,775 | $3,705 | $3,327 |
| Total Assets | $234,583 | $256,571 | $264,345 | $252,934 | $264,319 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,474 | 3,067 | 2,419 | 486 | 605 |
| Accrued Expenses | 6,476 | 5,777 | 4,144 | 3,889 | 4,007 |
| Other current liabilities | N/A | 25 | 25 | 49 | 1,013 |
| TOTAL | $9,896 | $10,649 | $7,897 | $5,556 | $6,574 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,946 | 1,780 | 1,309 | 1,132 | 949 |
| Other Non-Current Liabilities | 386 | 455 | 373 | 0 | 0 |
| TOTAL | $9,087 | $9,692 | $8,794 | $5,812 | $5,153 |
| Total Liabilities | $18,983 | $20,341 | $16,691 | $11,368 | $11,727 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,206 | 4,172 | 4,135 | 2,713 | 2,686 |
| Common Shares | 4 | 4 | 4 | 3 | 3 |
| Retained earnings | -197,915 | -175,521 | -161,220 | -99,560 | -84,168 |
| Other shareholders' equity | -7 | -19 | 4 | 9 | -11 |
| TOTAL | $215,600 | $236,230 | $247,654 | $241,566 | $252,592 |
| Total Liabilities And Equity | $234,583 | $256,571 | $264,345 | $252,934 | $264,319 |